The present disclosure provides methods of detecting a wnt-β-catenin-mediated cancer and an immunotherapy resistant cancer by detecting the presence of an associated biomarker. Further, methods of threating the wnt-β-catenin-mediated cancer or immunotherapy resistant cancer are provided.